Aug 24 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* US FDA AWARDS ORPHAN DRUG DESIGNATION TO PAXALISIB FOR MALIGNANT GLIOMA, INCLUDING DIPG
Aug 24 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* US FDA AWARDS ORPHAN DRUG DESIGNATION TO PAXALISIB FOR MALIGNANT GLIOMA, INCLUDING DIPG